Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
BIND Therapeutics Inc. (NASDAQ: BIND) shares declined 1.11 percent to close at $15.10 a share Tuesday. The stock traded between $14.76 and $15.89 on volume of 285,302 shares traded. Cowen and Co., Credit Suisse and Stifel Nicolaus have all recently initiated coverage on the company with a "buy" rating. Shares of BIND Therapeutics have gained approximately 7.0 percent since its initial public offering.
Get more information on BIND Therapeutics and free access to the in-depth equity report at:
www.FiveStarEquities.com/BIND
Demand Media Inc. (NYSE: DMD) shares declined 8.72 percent to close at $5.34 a share Tuesday. The stock traded between $5.31 and $5.85 on volume 1.15 million shares traded. The company announced it has accepted the resignation of Richard Rosenblatt as Chairman and CEO. Shares of Demand Media have fallen approximately 42.0 percent year-to-date.
Get more information on Demand Media free access to the in-depth equity report at:
www.FiveStarEquities.com/DMD
ITT Educational Services, Inc. (NYSE: ESI) shares gained 3.03 percent to close at $31.94 a share Tuesday. The stock traded between $31.87 and $33.29 on volume of 737,487 shares traded. Wells Fargo has recently upgraded its rating on the company to “outperform” from “market perform”. Shares of ITT Educational Services have fallen approximately 30.0 percent year-to-date.
Get more information on ITT Educational Services and free access to the in-depth equity report at:
www.FiveStarEquities.com/ESI
Molycorp Inc. (NYSE: MCP) shares dropped 21.41 percent to close at $5.58 a share Tuesday. The stock traded between $5.37 and $6.07 on volume of 34.23 million shares traded. The company announced plans for a $200 million share sale as it is running short of funds. Shares of Molycorp have fallen approximately 40.0 percent year-to-date.
Get more information on Molycorp and free access to the in-depth equity report at:
www.FiveStarEquities.com/MCP
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
info@fivestarequities.com